Reports for APOTEX INC

Company Name
APOTEX INC

Shortage reports

Actual shortage:

220 (7%)

Anticipated shortage:

0 (0%)

Avoided shortage:

10 (0%)

Resolved:

3124 (93%)

3354

Discontinuation Reports

To be discontinued:

25 (7%)

Discontinued:

342 (93%)

Reversed:

0 (0%)

367

146 (4%)

70 (29%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-VARENICLINE 0.5MG TABLET Resolved 2024-05-31 2024-07-05 229427
APO-VARENICLINE 0.5MG TABLET Resolved 2024-08-01 2024-08-23 234277
APO-VARENICLINE 1MG TABLET Resolved 2024-08-09 2024-08-23 234996
APO-VARENICLINE 1MG TABLET Resolved 2024-09-12 2024-11-15 237348
APO-VARENICLINE 0.5MG TABLET Resolved 2019-01-03 2019-06-24 71151
APO-VARENICLINE 0.5MG 1MG KIT TABLET Resolved 2019-02-05 2019-11-18 74839
APO-VARENICLINE 1MG TABLET Resolved 2019-02-06 2019-06-24 74935
APO-VENLAFAXINE XR 75.0MG CAPSULE (EXTENDED RELEASE) Resolved 2019-04-18 2019-05-21 82022
APO-VENLAFAXINE XR 37.5MG CAPSULE (EXTENDED RELEASE) Resolved 2019-06-12 2022-05-16 86341
APO-VENLAFAXINE XR 37.5MG CAPSULE (EXTENDED RELEASE) Resolved 2019-06-12 2019-07-02 86347
APO-VENLAFAXINE XR 75.0MG CAPSULE (EXTENDED RELEASE) Resolved 2019-06-12 2019-06-24 86364
APO-VENLAFAXINE XR 37.5MG CAPSULE (EXTENDED RELEASE) Resolved 2019-07-17 2020-07-10 89554
APO-VENLAFAXINE XR 75.0MG CAPSULE (EXTENDED RELEASE) Resolved 2019-07-17 2019-11-25 89557
APO-VENLAFAXINE XR 150MG CAPSULE (EXTENDED RELEASE) Actual shortage 2022-12-16 2023-08-18 178766
APO-VENLAFAXINE XR 75MG CAPSULE (EXTENDED RELEASE) Actual shortage 2023-04-21 2023-09-01 189999
APO-VENLAFAXINE XR 37.5MG CAPSULE (EXTENDED RELEASE) Actual shortage 2023-05-12 2023-09-01 192361
APO-VENLAFAXINE XR 75MG CAPSULE (EXTENDED RELEASE) Actual shortage 2023-06-09 2023-08-18 194581
APO-VENLAFAXINE XR 37.5MG CAPSULE (EXTENDED RELEASE) Resolved 2019-09-18 2019-11-16 94203
APO-VENLAFAXINE XR 75.0MG CAPSULE (EXTENDED RELEASE) Resolved 2019-11-20 2019-11-25 99320
APO-VENLAFAXINE XR 75.0MG CAPSULE (EXTENDED RELEASE) Resolved 2020-01-22 2020-09-14 103926
Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-LAMIVUDINE 300MG TABLET Discontinued 2018-09-07 2019-07-13 60560
APO-LAMIVUDINE HBV 100MG TABLET Discontinued 2018-09-07 2019-12-21 60563
APO-LATANOPROST-TIMOP Discontinued 2018-09-07 2018-09-15 60572
APO-LEVOCARB - TAB 25MG/250MG 25MG 250MG TABLET Discontinued 2018-09-07 2019-02-07 60576
APO-LISINOPRIL TABLET 10 MG 10MG TABLET Discontinued 2018-09-07 2019-02-02 60579
APO-LISINOPRIL TABLET 20 MG 20MG TABLET Discontinued 2018-09-07 2018-11-26 60582
APO-LISINOPRIL TABLET 5 MG 5MG TABLET Discontinued 2018-09-07 2019-02-13 60585
APO-LISINOPRIL/HCTZ 12.5MG 20MG TABLET Discontinued 2017-03-13 2017-03-13 1090
APO-LISINOPRIL/HCTZ 12.5MG 10MG TABLET Discontinued 2017-03-13 2017-03-13 1093
APO-LISINOPRIL/HCTZ 25MG 20MG TABLET Discontinued 2017-03-13 2017-03-13 1096
APO-LITHIUM CARBONATE 300MG CAPSULE Discontinued 2018-09-07 2018-09-15 60588
APO-LOPERAMIDE - TAB 2MG 2MG TABLET Discontinued 2017-03-31 2017-03-31 4930
APO-LORAZEPAM TAB 0.5MG 0.5MG TABLET Discontinued 2018-09-07 2018-12-28 60591
APO-LORAZEPAM TAB 1MG 1MG TABLET Discontinued 2018-09-07 2018-10-05 60594
APO-LOSARTAN 25MG TABLET Discontinued 2019-02-01 2019-02-02 74376
APO-LOSARTAN 50MG TABLET Discontinued 2018-09-10 2018-09-15 60987
APO-LOSARTAN 100MG TABLET Discontinued 2019-01-04 2019-01-04 71213
APO-LOSARTAN/HCTZ 12.5MG 100MG TABLET Discontinued 2018-09-07 2018-11-02 60597
APO-LOSARTAN/HCTZ 25MG 100MG TABLET Discontinued 2018-09-07 2018-12-28 60600
APO-LOSARTAN/HCTZ 12.5MG 50MG TABLET Discontinued 2018-09-07 2018-12-28 60603